IBDEI089 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3564,1,3,0)
 ;;=3^Encephalopathy,Toxic
 ;;^UTILITY(U,$J,358.3,3564,1,4,0)
 ;;=4^G92.
 ;;^UTILITY(U,$J,358.3,3564,2)
 ;;=^259061
 ;;^UTILITY(U,$J,358.3,3565,0)
 ;;=G93.40^^18^220^56
 ;;^UTILITY(U,$J,358.3,3565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3565,1,3,0)
 ;;=3^Encephalopathy,Unspec
 ;;^UTILITY(U,$J,358.3,3565,1,4,0)
 ;;=4^G93.40
 ;;^UTILITY(U,$J,358.3,3565,2)
 ;;=^329917
 ;;^UTILITY(U,$J,358.3,3566,0)
 ;;=Z13.858^^18^220^85
 ;;^UTILITY(U,$J,358.3,3566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3566,1,3,0)
 ;;=3^Nervous System Disorder Screening
 ;;^UTILITY(U,$J,358.3,3566,1,4,0)
 ;;=4^Z13.858
 ;;^UTILITY(U,$J,358.3,3566,2)
 ;;=^5062718
 ;;^UTILITY(U,$J,358.3,3567,0)
 ;;=G40.911^^18^220^57
 ;;^UTILITY(U,$J,358.3,3567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3567,1,3,0)
 ;;=3^Epilepsy,Intractable w/ Status Epilepticus,Unspec
 ;;^UTILITY(U,$J,358.3,3567,1,4,0)
 ;;=4^G40.911
 ;;^UTILITY(U,$J,358.3,3567,2)
 ;;=^5003866
 ;;^UTILITY(U,$J,358.3,3568,0)
 ;;=G40.919^^18^220^58
 ;;^UTILITY(U,$J,358.3,3568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3568,1,3,0)
 ;;=3^Epilepsy,Intractable w/o Status Epilepticus,Unspec
 ;;^UTILITY(U,$J,358.3,3568,1,4,0)
 ;;=4^G40.919
 ;;^UTILITY(U,$J,358.3,3568,2)
 ;;=^5003867
 ;;^UTILITY(U,$J,358.3,3569,0)
 ;;=G40.901^^18^220^59
 ;;^UTILITY(U,$J,358.3,3569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3569,1,3,0)
 ;;=3^Epilepsy,Not Intractable w/ Status Epilepticus,Unspec
 ;;^UTILITY(U,$J,358.3,3569,1,4,0)
 ;;=4^G40.901
 ;;^UTILITY(U,$J,358.3,3569,2)
 ;;=^5003864
 ;;^UTILITY(U,$J,358.3,3570,0)
 ;;=G40.909^^18^220^60
 ;;^UTILITY(U,$J,358.3,3570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3570,1,3,0)
 ;;=3^Epilepsy,Not Intractable w/o Status Epilepticus,Unspec
 ;;^UTILITY(U,$J,358.3,3570,1,4,0)
 ;;=4^G40.909
 ;;^UTILITY(U,$J,358.3,3570,2)
 ;;=^5003865
 ;;^UTILITY(U,$J,358.3,3571,0)
 ;;=G25.0^^18^220^61
 ;;^UTILITY(U,$J,358.3,3571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3571,1,3,0)
 ;;=3^Essential Tremor
 ;;^UTILITY(U,$J,358.3,3571,1,4,0)
 ;;=4^G25.0
 ;;^UTILITY(U,$J,358.3,3571,2)
 ;;=^5003791
 ;;^UTILITY(U,$J,358.3,3572,0)
 ;;=G25.9^^18^220^62
 ;;^UTILITY(U,$J,358.3,3572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3572,1,3,0)
 ;;=3^Extrapyramidal/Movement Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,3572,1,4,0)
 ;;=4^G25.9
 ;;^UTILITY(U,$J,358.3,3572,2)
 ;;=^5003803
 ;;^UTILITY(U,$J,358.3,3573,0)
 ;;=R29.810^^18^220^63
 ;;^UTILITY(U,$J,358.3,3573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3573,1,3,0)
 ;;=3^Facial Weakness
 ;;^UTILITY(U,$J,358.3,3573,1,4,0)
 ;;=4^R29.810
 ;;^UTILITY(U,$J,358.3,3573,2)
 ;;=^329954
 ;;^UTILITY(U,$J,358.3,3574,0)
 ;;=R25.3^^18^220^64
 ;;^UTILITY(U,$J,358.3,3574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3574,1,3,0)
 ;;=3^Fasciculation
 ;;^UTILITY(U,$J,358.3,3574,1,4,0)
 ;;=4^R25.3
 ;;^UTILITY(U,$J,358.3,3574,2)
 ;;=^44985
 ;;^UTILITY(U,$J,358.3,3575,0)
 ;;=R26.9^^18^220^65
 ;;^UTILITY(U,$J,358.3,3575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3575,1,3,0)
 ;;=3^Gait/Mobility Abnormalities,Unspec
 ;;^UTILITY(U,$J,358.3,3575,1,4,0)
 ;;=4^R26.9
 ;;^UTILITY(U,$J,358.3,3575,2)
 ;;=^5019309
 ;;^UTILITY(U,$J,358.3,3576,0)
 ;;=R51.^^18^220^66
 ;;^UTILITY(U,$J,358.3,3576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3576,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,3576,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,3576,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,3577,0)
 ;;=G81.92^^18^220^67
 ;;^UTILITY(U,$J,358.3,3577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3577,1,3,0)
 ;;=3^Hemiplegia,Affecting Lt Dominant Side,Unspec
